Spero Therapeutics, Inc. Profile Avatar - Palmy Investing

Spero Therapeutics, Inc.

Spero Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on identifying, developing, and commercializing treatments for multi-drug resistant (MDR) bacterial infections and rare diseases in the United States. The company's product can…

Biotechnology
US, Cambridge [HQ]

News

Theses · Events · Sentiments
End of SPRO's Analysis
CIK: 1701108 CUSIP: 84833T103 ISIN: US84833T1034 LEI: - UEI: -
Secondary Listings
SPRO has no secondary listings inside our databases.